6.P2 — Chemical
← BackItems
-
66500Quantitation in serum, plasma, urine or other body fluid (except amniotic flu...
-
665032 tests described in item 66500
-
665063 tests described in item 66500
-
665094 tests described in item 66500
-
665125 or more tests described in item 66500
-
66517Quantitation of bile acids in blood in pregnancy. Applicable not more than 3 ...
-
66518Investigation of cardiac or skeletal muscle damage by quantitative measuremen...
-
66519Investigation of cardiac or skeletal muscle damage by quantitative measuremen...
-
66522Faecal calprotectin test for the diagnosis of inflammatory bowel disease, if ...
-
66523Faecal calprotectin test for the diagnosis of inflammatory bowel disease, if ...
-
66536Quantitation of HDL cholesterol
-
66539Electrophoresis of serum for demonstration of lipoprotein subclasses, if the ...
-
66542Oral glucose tolerance test for the diagnosis of diabetes mellitus that inclu...
-
66545Oral glucose challenge test in pregnancy for the detection of gestational dia...
-
66548Oral glucose tolerance test in pregnancy for the diagnosis of gestational dia...
-
66551Quantitation of glycated haemoglobin performed in the management of establish...
-
66554Quantitation of glycated haemoglobin performed in the management of pre-exist...
-
66557Quantitation of fructosamine performed in the management of established diabe...
-
66560Microalbumin - quantitation in urine
-
66563Osmolality, estimation by osmometer, in serum or in urine - 1 or more tests
-
66566Quantitation of: (a) blood gases (including pO2, oxygen saturation and pCO2) ...
-
66569Quantitation of blood gases, bicarbonate and pH as described in item 66566 on...
-
66572Quantitation of blood gases, bicarbonate and pH as described in item 66566 on...
-
66575Quantitation of blood gases, bicarbonate and pH as described in item 66566 on...
-
66578Quantitation of blood gases, bicarbonate and pH as described in item 66566 on...
-
66581Quantitation of blood gases, bicarbonate and pH as described in item 66566 on...
-
66584Quantitation of ionised calcium (except if performed as part of item 66566) -...
-
66585Quantification of laboratory‑based BNP or NT‑proBNP testing in a patient with...
-
66586Quantification of BNP or NT-proBNP testing in a patient with diagnosed pulmon...
-
66587Urine acidification test for the diagnosis of renal tubular acidosis includin...
-
66590Calculus, analysis of 1 or more
-
66593Ferritin - quantitation, except if requested as part of iron studies
-
66596Iron studies, consisting of quantitation of: (a) serum iron; and (b) transfer...
-
66605Vitamins - quantitation of vitamins B1, B2, B3, B6 or C in blood, urine or ot...
-
66606A test described in item 66605 if rendered by a receiving APP - 1 or more tes...
-
66607Vitamins - quantitation of vitamins A or E in blood, urine or other body flui...
-
66610A test described in item 66607 if rendered by a receiving APP - 1 or more tests
-
66623All qualitative and quantitative tests on blood, urine or other body fluid fo...
-
66626Detection or quantitation or both (not including the detection of nicotine an...
-
66629Beta-2-microglobulin - quantitation in serum, urine or other body fluids - 1 ...
-
66632Caeruloplasmin, haptoglobins, or prealbumin - quantitation in serum, urine or...
-
66635Alpha-1-antitrypsin - quantitation in serum, urine or other body fluid - 1 or...
-
66638Isoelectric focussing or similar methods for determination of alpha-1-antitry...
-
66639A test described in item 66638 if rendered by a receiving APP - 1 or more tes...
-
66641Electrophoresis of serum or other body fluid to demonstrate: (a) the isoenzym...
-
66642A test described in item 66641 if rendered by a receiving APP - 1 or more tes...
-
66644C-1 esterase inhibitor - quantitation
-
66647C-1 esterase inhibitor - functional assay
-
66650Alpha-fetoprotein, CA-15.3 antigen (CA15.3), CA-125 antigen (CA125), CA-19.9 ...
-
66651A test described in item 66650 if rendered by a receiving APP, where no tests...
-
66652A test described in item 66650 if rendered by a receiving APP - other than th...
-
666532 or more tests described in item 66650 (Item is subject to rule 6)
-
66654Prostate specific antigen – quantitation in the monitoring of high-risk patie...
-
66655Prostate specific antigen—quantitation For any particular patient, applicable...
-
66656Prostate specific antigen (PSA) quantitation in the monitoring of previously ...
-
66659Prostate specific antigen (PSA), quantitation of 2 or more fractions of PSA a...
-
66660Prostate specific antigen (PSA), quantitation of 2 or more fractions of PSA a...
-
66662Quantitation of hormone receptors on proven primary breast or ovarian carcino...
-
66663A test described in item 66662 if rendered by a receiving APP - 1 or more tes...
-
66665Lead quantitation in blood or urine (other than for occupational health scree...
-
66666A test described in item 66665 if rendered by a receiving APP - 1 or more tes...
-
66667Quantitation of serum zinc in a patient receiving intravenous alimentation - ...
-
66671Quantitation of serum aluminium in a patient in a renal dialysis program - ea...
-
66674Quantitation of: (a) faecal fat; or (b) breath hydrogen in response to loadin...
-
66677Test for tryptic activity in faeces in the investigation of diarrhoea of long...
-
66680Quantitation of disaccharidases and other enzymes in intestinal tissue - 1 or...
-
66683Enzymes - quantitation in solid tissue or tissues other than blood elements o...
-
66686Performance of 1 or more of the following procedures: (a) growth hormone supp...
-
66695Quantitation in blood or urine of hormones and hormone binding proteins - ACT...
-
66696A test described in item 66695, if rendered by a receiving APP - where no tes...
-
66697Tests described in item 66695, other than that described in 66696, if rendere...
-
666982 tests described in item 66695 (Item is subject to rule 6)
-
667013 tests described in item 66695 (Item is subject to rule 6)
-
667044 tests described in item 66695 (This fee applies where 1 laboratory, or more...
-
667075 or more tests described in item 66695 (Item is subject to rule 6)
-
66711Quantitation in saliva of cortisol in: (a) the investigation of Cushing's syn...
-
66712Two tests described in item 66711 (Item is subject to rule 6)
-
66714A test described in item 66711, if rendered by a receiving APP, where no test...
-
66715Tests described in item 66711, other than that described in 66714, if rendere...
-
66716TSH quantitation
-
66719Thyroid function tests (comprising the service described in item 66716 and ei...
-
66722TSH quantitation described in item 66716 and 1 test described in item 66695 (...
-
66723Tests described in item 66722, that is, TSH quantitation and 1 test described...
-
66724Tests described in item 66722, if rendered by a receiving APP, other than tha...
-
66725TSH quantitation described in item 66716 and 2 tests described in item 66695 ...
-
66728TSH quantitation described in item 66716 and 3 tests described in item 66695 ...
-
66731TSH quantitation described in item 66716 and 4 tests described in item 66695 ...
-
66734TSH quantitation described in item 66716 and 5 tests described in item 66695 ...
-
66743Quantitation of alpha-fetoprotein in serum or other body fluids during pregna...
-
66749Amniotic fluid, spectrophotometric examination of, and quantitation of: (a) l...
-
66750Quantitation, in pregnancy, of any 2 of the following to detect foetal abnorm...
-
66751Quantitation, in pregnancy, of any three or more tests described in 66750 (It...
-
66752Quantitation of acetoacetate, beta-hydroxybutyrate, citrate, oxalate, total f...
-
667552 or more tests described in item 66752
-
66756Quantitation of 10 or more amino acids for the diagnosis of inborn errors of ...
-
66757Quantitation of 10 or more amino acids for monitoring of previously diagnosed...
-
66758Quantitation of angiotensin converting enzyme, or cholinesterase - 1 or more ...
-
66761Test for reducing substances in faeces by any method (except reagent strip or...
-
66764Examination for faecal occult blood (including tests for haemoglobin and its ...
-
667672 examinations described in item 66764 performed on separately collected and ...
-
667703 examinations described in item 66764 performed on separately collected and ...
-
66773Quantitation of products of collagen breakdown or formation for the monitorin...
-
66776Quantitation of products of collagen breakdown or formation for the monitorin...
-
66779Adrenaline, noradrenaline, dopamine, histamine, hydroxyindoleacetic acid (5HI...
-
66780A test described in item 66779 if rendered by a receiving APP - 1 or more tes...
-
66782Porphyrins or porphyrins precursors - detection in plasma, red cells, urine o...
-
66783A test described in item 66782 if rendered by a receiving APP - 1 or more tes...
-
66785Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urin...
-
66788Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urin...
-
66789A test described in item 66785 if rendered by a receiving APP, where no tests...
-
66790A test described in item 66785 other than that described in 66789, if rendere...
-
66791Porphyrin biosynthetic enzymes - measurement of activity in blood cells or ot...
-
66792A test described in item 66791 if rendered by a receiving APP - 1 or more tes...
-
66800Quantitation in blood, urine or other body fluid by any method (except reagen...
-
668032 tests described in item 66800 (Item is subject to rule 6)
-
66804A test described in item 66800 if rendered by a receiving APP, where no tests...
-
66805A test described in item 66800 other than that described in 66804, if rendere...
-
668063 tests described in item 66800 (Item is subject to rule 6)
-
66812Quantitation, not elsewhere described in this Table by any method or methods,...
-
668152 tests described in item 66812 (This fee applies where 1 laboratory, or more...
-
66816A test described in item 66812 if rendered by a receiving APP, where no tests...
-
66817A test described in item 66812, other than that described in 66816, if render...
-
66819Quantitation of copper, manganese, selenium, or zinc (except if item 66667 ap...
-
66820A test described in item 66819 if rendered by a receiving APP, where no tests...
-
66821A test described in item 66819 other than that described in 66820 if rendered...
-
66822Quantitation of copper, manganese, selenium, or zinc (except if item 66667 ap...
-
66825Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium,...
-
66826A test described in item 66825 if rendered by a receiving APP where no tests ...
-
66827A test described in item 66825, other than that described in 66826, if render...
-
66828Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium,...
-
66829Quantitation of BNP or NT‑proBNP for the exclusion of a diagnosis of heart fa...
-
66830Quantitation of BNP or NT-proBNP for the diagnosis of heart failure in patien...
-
66831Quantitation of copper or iron in liver tissue biopsy
-
66832A test described in item 66831 if rendered by a receiving APP (Item is subjec...
-
6683325-hydroxyvitamin D, quantification in serum, for the investigation of a pati...
-
66834A test described in item 66833 if rendered by a receiving APP (Item is subjec...
-
668351, 25-dihydroxyvitamin D - quantification in serum, if the request for the te...
-
668361, 25-dihydroxyvitamin D-quantification in serum, if: (a) the patient has hyp...
-
66837A test described in item 66835 or 66836 if rendered by a receiving APP (Item ...
-
66838Quantification of either or both of total vitamin B12 and holotranscobalamin ...
-
66839Quantification of methylmalonic acid or homocysteine, rendered in the same pa...
-
66840Serum folate test and, if required, red cell folate test for a patient at ris...
-
66841Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of d...
-
66842Quantification of one or more of total vitamin B12, holotranscobalamin, methy...
-
66900CARBON-LABELLED UREA BREATH TEST using oral C-13 or C-14 urea, including the ...